BioCryst Pharmaceuticals (NASDAQ:BCRX) has outperformed the market over the past 10 years by 5.6% on an annualized basis.
Buying $1,000 In BCRX: 10 years ago, an investor could have purchased 352.11 shares of BioCryst Pharmaceuticals at the time with $1,000. This investment in BCRX would have produced an average annual return of 19.4%. Currently, BioCryst Pharmaceuticals has a market capitalization of $3.01 billion.
BioCryst Pharmaceuticals’s Share Price Over Last 10 Years
This $1,000 investment would be worth $5,887.32 today based on a price of $16.73 for BCRX at the time of writing.
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
You can check out Benzinga’s market data in an enhanced view on Benzinga Pro
This article was generated by Benzinga’s automated content engine and reviewed by an editor.